Australian biotech Medigrowth has revealed plans for a new research facility in Geelong, with the goal of expanding clinical and commercial opportunities for medicinal cannabis products. But co-founder Adam Guskich says the project has an even larger goal: to develop the sector to a point where regulators, doctors and patients drop the term ‘cannabis’, and 

​ Australian biotech Medigrowth has revealed plans for a new research facility in Geelong, with the goal of expanding clinical and commercial opportunities for medicinal cannabis products. But co-founder Adam Guskich says the project has an even larger goal: to develop the sector to a point where regulators, doctors and patients drop the term ‘cannabis’, and […] 

​Read More 

Cannabis Law Report